All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0323-LX129 | Anti-HER3 VHH(X3XH129) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH129 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX130 | Anti-HER3 VHH(X3XH130) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH130 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX131 | Anti-HER3 VHH(X3XH131) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH131 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX498 | Anti-HER3 VHH(X3XH129) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH129 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX499 | Anti-HER3 VHH(X3XH130) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH130 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX500 | Anti-HER3 VHH(X3XH131) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH131 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX867 | Anti-HER3 VHH(X3XH129) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH129 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX868 | Anti-HER3 VHH(X3XH130) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH130 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX869 | Anti-HER3 VHH(X3XH131) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH131 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0823-LX67 | Anti-hHER3 (95) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | 95 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION